Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · October 24, 2024

Continuation vs Discontinuation of RAS Inhibitors Before Major Noncardiac Surgery

JAMA: The Journal of the American Medical Association

 

Additional Info

JAMA: The Journal of the American Medical Association
Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial
JAMA 2024 Sep 24;332(12)970-978, M Legrand, J Falcone, B Cholley, H Charbonneau, A Delaporte, A Lemoine, M Garot, A Joosten, C Meistelman, D Cheron-Leroy, JP Rives, B Pastene, A Dewitte, S Sigaut, M Danguy des Deserts, C Truc, M Boisson, S Lasocki, P Cuvillon, U Schiff, S Jaber, M Le Guen, A Caillard, S Bar, E Pereira de Souza Neto, V Colas, F Dimache, T Girardot, E Jozefowicz, S Viquesnel, F Berthier, E Vicaut, E Gayat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading